Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by SouthernTierTomon Apr 19, 2021 2:20pm
139 Views
Post# 33022966

RE:Market size update soon?

RE:Market size update soon?Thanks as always for your support MM!  The ability to have several other opinions north of the border has been of great help to both myself and other STIG members.

I am expecting an April 2021 presentation effort some time soon, let's hope many of your factual and astute observations are considered, even with a 90% discount.  My addition would come buy way of "subtraction"....what about the cost savings and the damage control to key organs?

* AKI and kdney / dialysis issues were as troublesome here as any in the intial wave that hit US hot-spots....dialysis equipment seemed to be at more of a premium than a ventilator at some points!

* PMX usage is known to reduce AKI...think of the savings both now and in the future care for an injured kidney(s)

* Obviously the DIMI has too many cost-savings to list, but the ability to have dialysis daily and run clean blood through the organs provides a benefit that is difficult to quantify...at least now and without your "wizardry" ; - )

* It is coming together and so nice to see our CMO involved in a Covid19 realated retro-spective study....let's see what the three states here in the NE have to say...I'm curious on the low-hanging fruit and the AKI expericnce of those critically ill survivors with and without PMX usage.  It's like the blood pressure benefit, we know it's there, let's just dress it up and let it out on the town for an evening...or two.

Estor just ran a presentation in Italy on pediactric usage and also transplant involvement...I still can't figure out how it helps the feet, but I'm always a ittle slow to catch on! ; - )

Bon chance,
Tom
<< Previous
Bullboard Posts
Next >>